enzastaurin has been researched along with Stomach Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bang, YJ; Choi, HJ; Im, SA; Kang, BC; Kim, HP; Kim, SG; Kim, TY; Kim, WH; Kwon, E; Lee, KW; Park, JH; You, J | 1 |
1 other study(ies) available for enzastaurin and Stomach Neoplasms
Article | Year |
---|---|
Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-Associated Death Protein; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Indoles; Mice; Mice, Nude; Mitochondria; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2008 |